clinical research



poster sessions


New research on the use of psychedelic drugs as treatment for a range of mental disorders appears to be throwing open doors of perception long closed within the medical community.
Los Angeles Times, September 2015

Discover the latest research into the benefits and risks of psychedelics and marijuana for psychotherapy, neuroscience, spirituality, and creativity, and more.

The Three-Day Conference (April 21-23) will feature three simultaneous tracks of presentations by leading and up-and-coming international researchers in the multidisciplinary field of psychedelic science and medicine. Presenters from around the world will share recently completed and ongoing research into the therapeutic, scientific, and spiritual uses of:

  • MDMA
  • LSD
  • Ayahuasca
  • Psilocybin
  • Ibogaine
  • Ketamine
  • Peyote
  • Medical marijuana
...and much more!



Clinical Research Track








Rick Doblin, Ph.D.
The Future of Psychedelic Therapy










Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N.
MDMA-Assisted Psychotherapy for PTSD: Lessons from Phase 2 Clinical Trials


David Nichols, Ph.D.
Psychedelic Neuroscience


David Nutt, D.M., F.R.C.P., F.R.C.Psych, F.Med.Sci.
Psychedelic Research: From Brain Imaging to Policy Reform



Marcela Ot'alora, M.A., L.P.C. and Bruce Poulter, R.N., M.P.H.
MDMA as Profound Change Agent: Insights from MDMA-assisted Psychotherapy for PTSD Research






Ben Sessa, M.B.B.S., M.D., B.Sc., M.R.C.Psych.
MDMA Therapy: A Child Psychiatrist's Perspective




Phil Wolfson M.D. and Julane Andries L.M.F.T.
MDMA-Assisted Psychotherapy for Anxiety in Life-Threatening Illness




Interdisciplinary Research Track












phil wolfson
chadi abdallah
richard roston
alison mcinnes

Phil Wolfson, M.D., Chadi G. Abdallah, M.D., Richard Roston, M.D., and Alison McInnes, M.D.
PANEL: Ketamine in Clinical Practice: Varieties, Research, and Opportunities


Katherine Hendy, Ph.D.
The Placebo Paradox


Monnica T. Williams, Ph.D., A.B.P.P., Jae Sevelius, Ph.D., and Ismail Ali, J.D.
PANEL: Psychedelics, Injustice, and the Intersectionality of Trauma


Stanley Krippner, Ph.D.
Remembering Salvador Roquet

philippe lucas sue sisley zach walsh

Philippe Lucas, M.A., Suzanne Sisley, M.D, Zach Walsh, Ph.D.
PANEL: Marijuana for PTSD


Ethan Nadelmann, Ph.D.
Drug Policy and Psychedelics








Sara Gael, M.A., Richard Gottlieb, R.N., Stefanie Jones, Katherine MacLean, Ph.D., Maria Carmo Carvalho
PANEL: Psychedelic Harm Reduction: Creating the Container









Plant Medicine Track

Organized by Bia Labate, Ph.D.











alexander dawson headshot

Alexander Dawson, Ph.D.
Peyote's Race Problem












o hayden griffin

O. Hayden Griffin, III, Ph.D.
The Therapeutic Potential of Kratom
























graham st john

Graham St. John, Ph.D.
DMT, Liminality, and Hyperspace








Share This Page